CVS capping purchases of Plan B pills to ensure consistent supply

CVS capping purchases of Plan B pills to ensure consistent supply


Protesters outside the Supreme Court following the overturning of Roe v. Wade.

Brandon Bell | Getty Images News | Getty Images

CVS is limiting the number of the emergency contraceptives commonly known as “morning after pills” and “Plan B” that people can buy on its website and in its stores after last week’s Supreme Court ruling.

The drug store chain said in a statement it had ample supply of the pills online and in stores, but that it wanted to ensure “equitable access and consistent supply on store shelves.” The move comes after the Supreme Court on Friday overturned the landmark ruling that had protected abortion as a constitutional right for nearly 50 years.

CVS Health said it began limiting purchases of Plan B and Aftera, which cost $49.99 and $39.99, respectively, to three per order on Saturday.

Walgreens does not have a purchase limit in place on emergency contraceptives, a representative for the chain said Monday. A representative for Walmart did not immediately respond to a request for comment. The Wall Street Journal reported sales limits on the pills by retailers earlier Monday.

Emergency contraceptive pills are often sold under the Plan B brand and can be purchased over-the-counter and without an ID or prescription. They work by preventing ovulation or preventing a fertilized egg from attaching to the womb and are taken in the days after unprotected sex, or after a contraceptive fails.

The pills are different from medication abortion, or abortion pills, which require a prescription and involve taking two different pills within 10 weeks of pregnancy, according to the Kaiser Family Foundation.

In the days following the Supreme Court’s decision last many, many people took to social media to urge people to stock up on contraceptive pills. Others said potential shortages could impact those most in need and urged people to instead fund organizations that help distribute the pills to keep it available.

–CNBC’s Melissa Repko contributed to this report.



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More